Alzinova AB (publ) (STO:ALZ)
Sweden · Delayed Price · Currency is SEK 0.8400
+0.0900 (12.00%)
Jul 24, 2026, 5:29 PM CET
Alzinova AB Market Cap
Alzinova AB has a market cap or net worth of 151.98 million as of July 24, 2026. Its market cap has decreased by -27.16% in one year.
Market Cap
151.98M
Enterprise Value
141.40M
Revenue
25.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.84
ChartMarket Cap Chart
Since November 25, 2015, Alzinova AB's market cap has increased from 57.35M to 151.98M, an increase of 165.01%. That is a compound annual growth rate of 9.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 151.98M | 75.73% |
| Dec 30, 2025 | 86.48M | -71.97% |
| Dec 30, 2024 | 308.51M | 128.27% |
| Dec 29, 2023 | 135.15M | 50.50% |
| Dec 30, 2022 | 89.80M | -11.61% |
| Dec 30, 2021 | 101.60M | -13.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 206.05M |
| IRLAB Therapeutics AB | 189.46M |
| Elicera Therapeutics AB | 175.52M |
| Simris Group AB (PUBL) | 174.12M |
| Initiator Pharma | 166.34M |
| Xintela AB | 162.78M |
| Diamyd Medical AB | 159.63M |
| Nanologica AB | 144.00M |